|Title:||An Implantable Depot That Can Generate Oxygen in Situ for Overcoming Hypoxia-Induced Resistance to Anticancer Drugs in Chemotherapy||Authors:||WEI-TSO CHIA||Issue Date:||2016||Journal Volume:||138||Journal Issue:||16||Start page/Pages:||5222-5225||Source:||Journal of the American Chemical Society||Abstract:||
In the absence of adequate oxygen, cancer cells that are grown in hypoxic solid tumors resist treatment using antitumor drugs (such as doxorubicin, DOX), owing to their attenuated intracellular production of reactive oxygen species (ROS). Hyperbaric oxygen (HBO) therapy favorably improves oxygen transport to the hypoxic tumor tissues, thereby increasing the sensitivity of tumor cells to DOX. However, the use of HBO with DOX potentiates the ROS-mediated cytotoxicity of the drug toward normal tissues. In this work, we hypothesize that regional oxygen treatment by an implanted oxygen-generating depot may enhance the cytotoxicity of DOX against malignant tissues in a highly site-specific manner, without raising systemic oxygen levels. Upon implantation close to the tumor, the oxygen-generating depot reacts with the interstitial medium to produce oxygen in situ, effectively shrinking the hypoxic regions in the tumor tissues. Increasing the local availability of oxygen causes the cytotoxicity of DOX that is accumulated in the tumors to be significantly enhanced by the elevated production of ROS, ultimately allaying the hypoxia-induced DOX resistance in solid malignancies. Importantly, this enhancement of cytotoxicity is limited to the site of the tumors, and this feature of the system that is proposed herein is unique. ? 2016 American Chemical Society.
|DOI:||10.1021/jacs.6b01784||SDG/Keyword:||Activation analysis; Chemotherapy; Cytotoxicity; Drug products; Electric resistance; Histology; Tumors; Hyperbaric oxygen therapies; Induced resistance; Interstitial medium; Intracellular production; Malignant tissues; Oxygen transport; Reactive oxygen species; Solid malignancy; Oxygen; alginic acid; calcium ion; doxorubicin; oxygen; antineoplastic agent; CA9 protein, human; calcium chloride; calcium peroxide; carbonate dehydratase IX; catalase; doxorubicin; oxygen; peroxide; tumor antigen; animal experiment; animal model; Article; controlled study; cytotoxicity; drug pellet; fluorescence; human; human cell; hypoxia; induced resistance; mouse; nonhuman; oxygen therapy; animal; chemistry; drug effect; drug implant; drug resistance; drug screening; hyperbaric oxygen therapy; metabolism; nude mouse; pharmacology; positron emission tomography; procedures; tumor cell line; tumor hypoxia; Animals; Antigens, Neoplasm; Antineoplastic Agents; Calcium Chloride; Carbonic Anhydrase IX; Catalase; Cell Line, Tumor; Doxorubicin; Drug Implants; Drug Resistance, Neoplasm; Humans; Hyperbaric Oxygenation; Mice, Nude; Oxygen; Peroxides; Positron-Emission Tomography; Tumor Hypoxia; Xenograft Model Antitumor Assays
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.